Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol in Eating Disorders
NCT03740204Phase 2Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2019
- Primary completion
- Dec 2025
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of estradiol in eating disorders, sponsored by Massachusetts General Hospital. Started Jun 2019; status: active, not recruiting.
02
Drugs
estradiol
03
Conditions
eating disorders
Beyond the preview
Go deeper on NCT03740204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740204.